v3.25.2
REVENUE RECOGNITION - Schedule of Revenue by Product (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Jun. 28, 2025
Jun. 29, 2024
Disaggregation of Revenue [Line Items]        
Net sales $ 1,056.3 $ 1,065.5 $ 2,100.2 $ 2,147.5
CSCA        
Disaggregation of Revenue [Line Items]        
Net sales 622.0 634.1 1,242.8 1,278.3
CSCA | Upper Respiratory        
Disaggregation of Revenue [Line Items]        
Net sales 123.3 118.8 261.2 249.1
CSCA | Digestive Health        
Disaggregation of Revenue [Line Items]        
Net sales 109.7 126.0 212.7 248.2
CSCA | Nutrition        
Disaggregation of Revenue [Line Items]        
Net sales 95.6 86.1 200.3 176.7
CSCA | Pain and Sleep-Aids        
Disaggregation of Revenue [Line Items]        
Net sales 80.2 81.6 156.8 164.2
CSCA | Healthy Lifestyle        
Disaggregation of Revenue [Line Items]        
Net sales 73.7 69.1 144.1 140.4
CSCA | Oral Care        
Disaggregation of Revenue [Line Items]        
Net sales 60.0 73.2 122.0 137.9
CSCA | Skin Care        
Disaggregation of Revenue [Line Items]        
Net sales 57.8 57.1 106.3 106.7
CSCA | Women's Health        
Disaggregation of Revenue [Line Items]        
Net sales 18.7 16.8 33.7 44.0
CSCA | Vitamins, Minerals, and Supplements ("VMS")        
Disaggregation of Revenue [Line Items]        
Net sales 2.1 5.3 3.8 9.5
CSCA | Other        
Disaggregation of Revenue [Line Items]        
Net sales 0.9 0.1 1.8 1.6
CSCI        
Disaggregation of Revenue [Line Items]        
Net sales 434.3 431.3 857.4 869.3
CSCI | Upper Respiratory        
Disaggregation of Revenue [Line Items]        
Net sales 55.4 50.7 128.9 119.8
CSCI | Digestive Health        
Disaggregation of Revenue [Line Items]        
Net sales 9.9 8.5 19.5 18.0
CSCI | Pain and Sleep-Aids        
Disaggregation of Revenue [Line Items]        
Net sales 63.5 50.3 117.1 101.7
CSCI | Healthy Lifestyle        
Disaggregation of Revenue [Line Items]        
Net sales 60.7 57.5 127.3 122.1
CSCI | Oral Care        
Disaggregation of Revenue [Line Items]        
Net sales 25.2 23.0 47.7 51.7
CSCI | Skin Care        
Disaggregation of Revenue [Line Items]        
Net sales 122.9 127.7 234.4 242.4
CSCI | Women's Health        
Disaggregation of Revenue [Line Items]        
Net sales 41.1 36.9 73.5 68.9
CSCI | Vitamins, Minerals, and Supplements ("VMS")        
Disaggregation of Revenue [Line Items]        
Net sales 38.6 39.9 76.2 84.5
CSCI | Other        
Disaggregation of Revenue [Line Items]        
Net sales $ 16.9 $ 36.8 $ 32.8 $ 60.1